Comments
Loading...
Latest Enliven Therapeutics Stock News | NASDAQ:ELVN | Benzinga
Get the latest news on Enliven Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Enliven Therapeutics performance
Categories: All
Tuesday, April 08, 2025
Friday, March 21, 2025
Thursday, March 13, 2025
Friday, December 13, 2024
Friday, November 15, 2024
Wednesday, November 13, 2024
Thursday, October 31, 2024
Monday, October 14, 2024
Tuesday, October 01, 2024
Saturday, September 28, 2024
Thursday, September 19, 2024
Wednesday, September 18, 2024
Monday, September 09, 2024
Tuesday, August 13, 2024
Tuesday, June 11, 2024
Tuesday, May 14, 2024
Thursday, April 11, 2024
- Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
- Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Enliven Therapeutics shares are trading highe...
- Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
- Enliven Therapeutics Announces Proof Of Conce...
Tuesday, April 09, 2024
Thursday, March 28, 2024
Tuesday, March 19, 2024
- Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
- Enliven Therapeutics shares are trading highe...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Enliven Therapeutics Announces $90M Private P...
Thursday, March 14, 2024
Monday, February 26, 2024
Tuesday, January 16, 2024
Thursday, November 09, 2023
Friday, September 29, 2023
Tuesday, August 29, 2023
Monday, August 14, 2023
Thursday, August 10, 2023
Wednesday, May 31, 2023
Thursday, May 11, 2023
Wednesday, March 29, 2023
Friday, March 03, 2023
Tuesday, February 28, 2023
- Enliven Therapeutics Chief Financial Officer Awarded $5.47M Worth of Stock Options
- Chief Scientific Officer at Enliven Therapeutics Acquires Company Stock Options Worth 433,081 Shares
- Enliven Therapeutics Chief Operating Officer Awarded $1.86M Worth of Stock Options
- Enliven Therapeutics Board Member Awarded $1.82M Worth of Stock Options
